Response to initial griseofulvin therapy in pediatric patients with tinea capitis

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 406-410

  Abdel Rahman, Susan M ^a   Nahata, Milap C ^a   Powell, Dwight A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

griseofulvin; tinea capitis

Indexed keywords

ANTIFUNGAL AGENT; GRISEOFULVIN;

ARTICLE; CHILD; CHILDHOOD DISEASE; FEMALE; FUNGUS CULTURE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RACE DIFFERENCE; RECURRENT DISEASE; SEX DIFFERENCE; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 0030909899     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100403     Document Type: Article

References (23)

1. Rosenthal JR. Pediatric fungal infections from head to toe: what's new? Curr Opin Pediatr 1994;6:435-41.
2. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995;8:240-59.
3. Allen MB, Honig PJ, Leyden JJ, McGinley KJ. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics 1982;69:81-3.
4. Williams DI, Marten RH. Oral treatment of ringworm with griseofulvin. Lancet 1958;2:1212-3.
5. Frieden IJ, Howard R. Tinea capitis: epidemiology, diagnosis, treatment, and control. J Am Acad Dermatol 1994;31(suppl):S42-6.
6. Schwartz RA, Janniger CK, Tinea capitis. Cutis 1995;55:29-33.
7. Elewski BE. Tinea capitis: itraconazole in Trichophyton tonsurans infections. J Am Acad Dermatol 1994;31:65-7.
8. Jacobs PH. Treatment of fungal skin infections: state of the art. J Am Acad Dermatol 1990;23:549-51.
9. Presser SE, Blank H. Cimetidine: adjunct in treatment of tinea capitis. Lancet 1981;1:108-9.
10. Alvi KH, Iqbal N, Khan KA, Haroon TS, Hussain I, Aman S, et al. A randomized double-blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in the treatment of tinea capitis. In: Shuster S, Jafary MH, eds. Royal Society of Medicine Services International Congress Series No. 205,1992:35-40.
11. Lopez-Gomez S, Del Palacio A, Van Custem J, Cuetara MS, Iglesias L, Rodriguez-Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol 1994;33:743-7.
12. Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: should ketoconazole replace griseofulvin? J Pediatr 1988;112:987-91.
13. Martinez-Roig A, Torres-Rodriguez JM, Bartlett-Coma A. Double blind study of ketoconazole and griseofulvin in dermatophytoses. Pediatr Infect Dis J 1988;7:37-40.
14. Laude TA, Shah BR, Lynfield Y. Tinea capitis in Brooklyn. Am J Dis Child 1982;136:1047-50.
15. Ginsburg CM, McCraken GH Jr, Petruska M, Olsen K. Effects of feeding on bioavailability of griseofulvin in children. J Pediatr 1983;102:309-11.
16. Bronson DM, Desai DR, Barsky S, Foley SM. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago. J Am Acad Dermatol 1983;8:322-30.
17. Prevost E. Nonfluorescent tinea capitis in Charleston, SC. JAMA 1979;242:1675-7.
18. Ayd FJ. Once-a-day neuroleptic and tricyclic antidepressant therapy. Int Drug Ther Newslett 1972;7:33.
19. American Academy of Pediatrics. 1994 Red book: report of the committee on infectious diseases. 23rd ed. Elk Grove, IL: American Academy of Pediatrics, 1994:463-4.
20. Fitzpatrick RE, Newcomer VD. Dermatophytosis and candidiasis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious disease. Philadelphia: WB Saunders Company, 1992:804.
21. Gan VN, Petruska M, Ginsburg CM. Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin. Pediatr Infect Dis J 1987;6:46-9.
22. Legendre R, Esola-Macre J. Itraconazole in the treatment of tinea capitis. J Am Acad Derm 1990;23:559-60.
23. Haroon TS, Hussain I, Mahmood A, Nagi AH, Ahmad I, Zahid M. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis. Br J Dermatol 1992;126:47-50.